Drug therapy in minimal brain dysfunction: a commentary.
D000661:Amphetamine / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D001921:Brain / Q000187:drug effects; D001925:Brain Damage, Chronic / Q000188:drug therapy*; D002648:Child; D002653:Child Behavior Disorders / Q000188:drug therapy; D002746:Chlorpromazine / Q000627:therapeutic use; D003913:Dextroamphetamine / Q000627:therapeutic use; D006801:Humans; D007859:Learning Disabilities / Q000188:drug therapy; D008774:Methylphenidate / Q000627:therapeutic use; D013881:Thioridazine / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D000927:Anticonvulsants; D000928:Antidepressive Agents; D014149:Tranquilizing Agents; D008774:Methylphenidate; D000661:Amphetamine; D013881:Thioridazine; D003913:Dextroamphetamine; D002746:Chlorpromazine